Skip to main content
Toggle navigation
Menu
Home
Medicines
COVID-19 vaccines
Browse medicine A-Z
Browse active ingredient A-Z
Medicines with black triangle
Discontinued medicines
RMM directory
Companies
Latest updates
About emc
Help
Log in
Sign up
Search emc: Enter medicine name or company
Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search
Back to top
capecitabine
11 products found
Capecitabine 150 mg film-coated tablets
capecitabine
Glenmark Pharmaceuticals Europe Ltd
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine 150 mg film-coated tablets
capecitabine
Amarox Limited
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine 150 mg film-coated tablets (PL 25258/0380)
capecitabine
Glenmark Pharmaceuticals Europe Ltd
Patient Leaflet (PIL)
Capecitabine 500 mg film-coated tablets
capecitabine
Glenmark Pharmaceuticals Europe Ltd
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine 500 mg film-coated tablets
capecitabine
Amarox Limited
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine 500 mg film-coated tablets (PL 25258/0381)
capecitabine
Glenmark Pharmaceuticals Europe Ltd
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine Accord 150 mg film coated tablets
capecitabine
Accord Healthcare Limited
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine Accord 300 mg film coated tablets
capecitabine
Accord Healthcare Limited
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine Accord 500 mg film coated tablets
capecitabine
Accord Healthcare Limited
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine Dr. Reddys 150 mg Film-Coated Tablets
capecitabine
Dr. Reddy's Laboratories (UK) Ltd
Health Professionals (SmPC)
Patient Leaflet (PIL)
Capecitabine Dr. Reddys 500 mg Film-Coated Tablets
capecitabine
Dr. Reddy's Laboratories (UK) Ltd
Health Professionals (SmPC)
Patient Leaflet (PIL)
Items per page
50
200
Page 1 of 1
Skip to main content
Back to top
Back to top
